Author: Mokhtar

  • Influence of the 2000-meter ergometer test on indirect markers of intestinal injury in competitive elite rowers in different training phases  BMC Sports sciences, medicine and rehabilitation

    Influence of the 2000-meter ergometer test on indirect markers of intestinal injury in competitive elite rowers in different training phases BMC Sports sciences, medicine and rehabilitation

    Attendees

    Eighteen male members of the National Polish Rowing Team (heavyweight rowers) were recruited, but only 10 met the inclusion criteria and participated in the study; all participants completed the two ergometer tests of 2000 meters. Before each test, anthropometric parameters were assessed using an electronic scale to the nearest 0.05 kg (Tanita BC-980 MA, Tanita Corporation, Tokyo, Japan). The results are shown in Table 1. The study was conducted by following the Declaration of Helsinki. The study protocol was approved by the local ethics committee of Poznań University of Medical Sciences (decision No. 314/22 in 2022). All participants were informed of the study procedures and gave their written consent.

    Table 1 The anthropometric characteristics of the participants (in the morning after an overnight fast before tests I and II).

    Inclusion criteria

    The inclusion criteria were a minimum of 5 years of training, a minimum total training time of 240 minutes per week, membership of the Polish rowing team and completion of the 2000 meter ergometer test.

    Exclusion criteria

    The exclusion criteria were antibiotic therapy, probiotics, prebiotics, metformin, dietary regimen, and health problems in the past three months.

    Training program

    The exercise profile, including intensity, volume (in minutes), and type (specific, i.e., rowing: endurance, speed, technical; and nonspecific: strength, jogging), was recorded daily. In addition, the intensity of the training was classified based on the LA threshold (4 mmol/l): an extensive (below the LA threshold) or an intensive (above the LA threshold) workload (Table 2).

    Table 2 Pre-test training program

    Food intake

    Total food intake was analyzed by a dietitian before each test using the 24-hour dietary recall method. The dietitian carefully checked each questionnaire and was available to participants during all meals. Energy, carbohydrates, proteins and fats were then measured via the commercially available DietetykPro program (DietetykPro, Wrocław, Poland).

    figure 1
    Figure 1

    The research design and timeline

    Exercise test

    For tests I and II, the athletes performed a controlled test at a distance of 2000 m (Fig. 1). The break between tests was almost 10 weeks (68 days). Test I was conducted at the beginning of the preparatory phase, while Test II was conducted at the beginning of the competitive phase. The participants rowed a distance of 2000 m as quickly as possible on the ergometer (Concept II, USA), as the test results were taken into account when selecting for the champion team. The athletes were therefore highly motivated to perform both tests with maximum effort. The exercise test was performed every day at 10:00 am. Before the test, participants ate a small, light meal and were hydrated (Table 1). Before testing, each participant completed an individual 5-minute warm-up.

    Collect and research material

    Samples were collected at the same three time points: before (before training), after an overnight fast; Post (immediately after training) and recovery (after 1 hour of recovery) for tests I II.

    Blood samples were collected from the antecubital vein into 9 ml polyethylene tubes (to obtain serum) and centrifuged at 3000 rpm for 10 minutes. The serum was frozen and stored at −80°C until analysis. In addition, capillary blood samples were collected from the earlobe before and immediately after the exercise test to assess LA levels.

    Dimensions

    Serum zonulin, intestinal fatty acid binding protein (I-FABP), LPS, LBP, and interleukin 6 (IL-6) were measured using commercially available enzyme-linked immunosorbent assays (ELISAs; SunRed Biotechnology Company, Shanghai, China). The test range was 0.25–70 ng/ml for zonulin, 0.3–80 ng/ml for I-FABP, 12–4000 endotoxin units (EU)/l for LPS, 0.2–60 µg/ml for LBP and 1–300 ng/l for IL-6. In addition, LA in capillary blood was measured immediately after sampling using a commercially available kit (Diaglobal, Berlin, Germany). The LA concentrations are presented as mmol/l.

    static analysis

    Statistical analysis was performed using GraphPad Prism 9 (GraphPad Software, USA). Descriptive statistics such as mean and standard deviation were used to identify patterns and trends. To investigate whether the variables had a normal distribution, the Shapiro-Wilk test was performed. To measure the equality of variances, the Brown-Forsythe test was used. One-way repeated measures analysis of variance (ANOVA), with Tukey’s post hoc analysis, was used to assess differences in measured variables from the three assessment points (Pre, Post, and Recovery) for Tests I and II. A t test was used to compare food intake, anthropometric characteristics and 2000-m test results (power, time and LA) between tests I and II. Cohen’s d was calculated to determine effect size. It was interpreted as small (0.2), moderate (0.5), or large (0.8) (Cohen, 1988). For correlation analysis, Pearson linear correlation coefficients were calculated. Significance of all statistical analyzes was set at p ≤ 0.05. Based on a power analysis, all tests that produced significant results had a power above 0.9, as calculated by G Power 3.1(G Power, (13).

    Source link

  • Appointment of deputy general manager

    Appointment of deputy general manager

    Appointment of Sandrine Carle
    as deputy general manager

    Ecully, November 7, 2023-The Spineway Group, specialists in innovative implants for the treatment of serious spinal disorders, announces the appointment of Sandrine Carle as Deputy Chief Executive Officer. Ms. Carle joined Spineway in July 2022, at the time of the acquisition of Spine Innovations, where she was CEO. She was instrumental in the successful integration of Spine Innovations into the Spineway Group.

    After obtaining a degree in biomedical engineering (UT Compiègne) and an Executive MBA at HEC in Paris, Sandrine Carle worked for more than 20 years in the orthopedic surgery sector, and more specifically in the spine surgery sector at Medtronic (Europe), Kyphon (USA) and Vexim (France). She held marketing and management positions in France and the US before being appointed CEO of Spine Innovations in 2020.

    Ms. Carle led the creation of this entity following a spin-off in 20201 and the development of this activity between 2020 and 2022. She led the recruitment and management of about fifteen employees, set up the functional and operational organization of the team and also obtained the company’s certification from the notified body G-MED (France ).

    Together with Stéphane Le Roux, CEO of Spineway, Sandrine Carle is responsible for executing the Group’s overall roadmap, in particular the business development plan aimed at returning to operational break-even,2 as well as all R&D projects (short, medium and long term).

    Stéphane Le Roux said: “I am pleased that Sandrine is joining me as Deputy Chief Executive Officer of Spineway. I am confident that her leadership, strategic insight and deep market knowledge will help shape our future. She will strengthen our highly experienced management team. Sandrine will also lead the Group’s development plan as we remain committed to our core values ​​of quality and innovation. She will work closely with me, our management team and all our employees to achieve our goal: to become an innovative player in France and internationally, a leader in less invasive spine treatments.”

    Next event:
    November 10, 2023: Extraordinary General Meeting

    SPINEWAY ELIGIBLE FOR PEA-SME (Small and Medium Business Equity Savings Plans)
    Find out all about Spineway at www.spineway.com

    This press release has been drawn up in both English and French. In case of contradictions, the French version shall prevail.

    Spineway designs, produces and sells innovative implants and surgical instruments for the treatment of serious spinal conditions.
    Spineway has an international network of more than 50 independent distributors and 90% of its turnover comes from exports.
    Spineway, which is eligible for investment through FCPIs (French unit trusts specialized in innovation), has received the OSEO Excellence Award since 2011 and the Deloitte Fast 50 Award (2011). Rhône Alpes INPI Patent Innovation Award (2013) – INPI Talent Award (2015).
    ISIN: FR001400BVK2 – ALSPW

    Contacts:

    SPINEWAY

    Shareholder services line

    Available from Tuesday to Thursday

    +33 (0)806 706 060

    Suitable PEA/PME

    ALSPW

    Euonext growth

    HEAVEN

    Office & Communications

    Relations with investors

    Solène Kennis

    Spineway@aelium.fr


    1 Spine Innovations was a spin-off born in 2020 from the sale of Groupe FH Orthopedics (France) to the Spineway Group.
    2 Positive operating result

    SPINEWAY

    Source link

  • Zimmer Biomet reports third quarter 2023 financial results

    Zimmer Biomet reports third quarter 2023 financial results

    • Third quarter net sales of $1.754 billion increased 5.0% and 4.7% at constant exchange rates1 base
    • Third quarter diluted earnings per share were $0.77; adjusted1 diluted earnings per share were $1.65
    • The company updates reported 2023 revenue expectations due to currency expectations and reaffirms consistent 2023 foreign exchange revenue growth and adjusted1 financial guidelines for earnings per share

    WARSAW, Ind., Nov. 7, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2023. The company reported third quarter net sales of $1.754 billion, up 5.0% from the same period last year, and an increase of 4.7% at constant exchange rates1 base. Net income for the third quarter was $162.7 million, or $346.5 million adjusted1 base.

    Diluted earnings per share were $0.77 for the third quarter and were adjusted1 diluted earnings per share were $1.65.

    1. Reconciliations of these measures to the corresponding US generally accepted accounting principles are included in this press release.

    “We are very pleased to report another Zimmer Biomet quarter of strong revenue growth and earnings per share. Our team continues to successfully drive execution and growth with a focus on innovation to create value for the stakeholders we serve,” said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. “As the new CEO of ZB, I am more confident than ever in our team, our full-year expectations for 2023 and that our solid growth – both top and bottom line – will continue in 2024.”

    Recent Highlights

    In line with the ongoing transformation of Zimmer Biomet’s business, key recent highlights include:

    • Appointment of Ivan Tornos as President and Chief Executive Officer and expansion of Chief Financial Officer Suketu (Suky) Upadhyay’s role to CFO and EVP, Finance, Operations & Supply Chain as part of Zimmer Biomet’s increased focus on innovation and commercial execution
    • Major updates to the Zimmer Biomet Executive Leadership Team, including the promotion of Wilfred van Zuilen to Group President, EMEA and Mark Bezjak to President of the Americas, as well as the appointment of Chief Science, Technology and Innovation Officer Nitin Goyal, MD to the Executive Leadership team
    • Registration of 100,000 patients since the launch of mymobility® care management platform, which provides a guided orthopedic patient experience, with automation, data and insights for physicians
    • Continued recognition for our Environmental, Social and Governance (ESG) programs with inclusion on the Newsweek Americas Greenest Companies 2024 and Sustainability Magazine Top 10: Sustainable Healthcare Device Companies lists

    Geographic and product category sales

    The following sales tables provide results by geography and product category for the three- and nine-month periods ended September 30, 2023, as well as the percentage change compared to the applicable prior year period, both on a reported and constant currency basis.

    SEE FINANCES HERE

    Source link

  • Testing the athletic shoulder with Ben Ashworth

    Testing the athletic shoulder with Ben Ashworth

    Standardized tests are often performed in the health and performance world to establish baselines, monitor performance, or help an athlete return to sports.

    The lower extremity has received the most attention, but the ASH test, or athletic shoulder test, popularized by Ben Ashworth, is a great option for the upper extremity.

    In this episode I talk to Ben about the ASH test and how to best use it for both rehabilitation and performance.

    Special offer for Ben’s online courses

    ben asworth athletic shoulder online course

    Plus, Ben was super friendly and gets a great discount on his new online courses on testing and training the athletic shoulder! Click the button below and make sure you use the coupon code REYNOLD at checkout!

    https://mikereinold.com/athleticshoulder/

    Show notes

    Ben works as a consultant with teams and individuals to solve shoulder performance issues. He has over twenty years of experience as a practitioner with Masters degrees in both Physiotherapy and Strength & Conditioning.

    Social tools for COS:
    – Instagram: @athleticshoulder



    Source link

  • Research shows that depression increases the risk of disability in patients with rheumatoid arthritis

    Research shows that depression increases the risk of disability in patients with rheumatoid arthritis

    In a review published in Nature Reviews Rheumatologyresearchers discussed the interactions between central and peripheral immunobiological mechanisms associated with rheumatoid arthritis (RA) and major depressive disorder (MDD).

    They further described the role of inflammatory proteins, the effect of peripheral inflammation on different parts of the brain, and the relationship between changes in the brain and inflammation-induced depression.

    Study: Immune mechanisms of depression in rheumatoid arthritis.  Image credits: pikselstock/Shutterstock.comStudy: Immune mechanisms of depression in rheumatoid arthritis. Image credits: pikselstock/Shutterstock.com

    Background

    RA is a chronic autoimmune inflammatory disease that negatively affects synovial joints and several other organs. Depression is a common, clinically heterogeneous condition that affects all other patients with RA. There is increasing evidence that RA and depression have overlapping features and can be modulated by each other.

    Data suggest that depression is a risk factor for RA, and that patients diagnosed with RA at a young age are more susceptible to depression. Furthermore, RA patients with depression are observed to exhibit functional progression as well as decreased response to treatment, leading to poor outcomes. However, the precise biological mechanisms underlying this association are not clearly understood.

    Therefore, this review focuses on understanding the link between these two conditions and the underlying mechanisms, while exploring the interplay between the nervous system and the immune system in RA patients.

    Shared cytokines in RA and depression

    Proinflammatory cytokines amplified in RA are also known to be causally linked to depression. Several cytokines have been implicated in RA and depression, including interleukin (IL)-16, IL-18, IL-1, IL-6, and tumor necrosis factor (TNF).

    Peripheral immune signals to the brain

    The peripheral immune system signals the brain through two known pathways: neural and humoral. In the neural pathway, molecules that mediate inflammation can bind and activate receptors on sensory neurons, including those in the dorsal root ganglia (DRG) and the vagus nerve.

    The activated sensory neurons then send the signal back to the cerebral cortex of the brain via the spinal cord. The signal is then passed on to higher brain centers, which modulate the immune system locally and systemically.

    Through the humoral pathway, immune cells release molecules capable of crossing the blood-brain barrier (BBB) ​​and affecting brain cells or activating the endothelial cells of BBB.

    As observed in experimental studies in mice, this pathway leads to the release of chemokines involved in neuronal plasticity, resulting in depression-like behavior and cognitive impairment.

    Immune responses in the brain

    In the brain, existing neural cells and recruited immune cells release various inflammatory proteins that support neuroimmune communication. When cytokines and chemokines are released by neurons, microglia, astrocytes, peripheral immune cells and endothelial cells, they influence neurological and immunological processes.

    For example, during inflammation, the recruitment of peripheral monocytes to the brain is associated with dendritic remodeling and cognitive impairment, potentially leading to depression. Chronic peripheral inflammation in RA induces local microglial activation in the brain, leading to altered microglial expression.

    Although microglia are often associated with inflammatory changes in the brain, recent studies indicate a more complex role for microglia in neurological health.

    Contrary to previous belief, microglia found in the brain, according to studies in mice, originate not only from peripheral blood, but also from meninges and bone marrow in the skull. However, there is a lack of studies examining this aspect in humans.

    Astrocytes also play a role in brain inflammation. Activation of astrocytes by cytokines from microglia has been shown to result in the release of neurotoxic factors that influence neuronal health and behavior.

    Mechanisms linking depression and inflammation

    Immune-related inflammation has been implicated in the pathophysiology of depression. In RA, several pathways are activated, which can lead to inflammation-related behavior.

    These pathways include inflammasome activation, the kynurenine pathway, neuroplasticity, and the pathways of the glutamatergic and serotonergic systems.

    Regional variation in the brain

    Although regional changes in the brain and the underlying mechanisms continue to be studied, mainly using animal models, neuroimaging studies in humans have significantly improved our understanding of inflammation-related changes in the brain.

    Advances in magnetic resonance imaging (MRI) have provided insights into the role of inflammation in depression beyond traditional structural assessments and histology-based studies. Emerging evidence suggests that the brain regions affected by inflammation and depression are the striatum, hippocampus, amygdala, and insula.

    Conclusion

    This review article provides a comprehensive overview of the association between immune mechanisms and depression in patients with rheumatoid arthritis. It highlights the need for further research in this area.

    Furthermore, data from clinical trials suggest that immune modulation may be a promising approach for treating comorbid depression in patients with rheumatoid arthritis, potentially reducing the global burden of this debilitating condition.

    Source link

  • Sports managers need sports trainers for a better heat policy

    Sports managers need sports trainers for a better heat policy

    Exercise-induced heat illness: policy adoption and influence on contextual factors reported by athletic administrators

    Scarneo-Miller SE, Adams WM, Coleman KA, Lopez RM. Sports Health. Mar 5, 2023: 19417381231155107. doi: 10.1177/19417381231155107. E-publishing prior to printing. PMID: 36872595.

    https://journals.sagepub.com/doi/10.1177/19417381231155107

    Take home message

    Most high school athletic administrators reported having a written heat illness policy in place, but they were often missing key components. The presence of an athletic trainer helped create a written policy that included more components.

    Background

    Sports administrators play an important role in policy acceptance. Policy measures such as addressing acute heat illness are critical as improper management can lead to poor outcomes. Unfortunately, we know little about the factors that promote and hinder the implementation of heat illness policies.

    Study aim

    The authors surveyed high school athletic administrators in the United States to describe the adoption of exertional heat illness policies and to examine factors that influence the adoption of these policies.

    Methods

    During the 2018-2019 academic school year, the research team emailed nearly 7,000 athletic administrators inviting them to complete a questionnaire asking about 1) demographics, 2) exercise-related illness policies, 3) monitoring and modification of written policy, and 4) enablers and barriers to policy development. The researchers used the precautionary adoption process model to assess an athletics administrator’s willingness to adopt policies. The adoption model is based on 8 phases, from not being aware to maintaining a written policy for more than 6 months.

    Results

    Of 466 athletics administrators (~48 years old, 82% male, 77% worked in the field for more than 15 years), 78% reported having a written policy on the prevention and treatment of exertional heat illness. Only 6% adopted all eleven essential elements of an exertional heat illness policy. Almost half of the managers indicated that they adopted fewer than 5 essential elements.

    Older athletics administrators, those who had previously dealt with heat illness, or those with an athletic trainer on their staff were more likely to have a written policy. Additionally, state mandates and having a medical professional were the most commonly cited facilitators for adopting policies on exertional illness prevention and use of a rectal thermometer. Similarly, the most commonly reported barrier to comprehensive heat illness management was the lack of a full-time athletic trainer (11). Administrators also recognized budget constraints that limited the use of a cold water immersion pool (23%), and the top barriers to using a rectal thermometer were discomfort using the thermometer (32%), parent/guardian resistance (30 %), resistance from parents/guardians (30%). coaches (30%) and liability issues (27%).

    Viewpoints

    Nearly 80% of athletics administrators surveyed reported that they had a written policy on exertional heat illness. Few integrated or were aware of all the necessary components to meet best clinical practices. The authors found that access to athletic training services was associated with better adoption of exercise health policies. This finding is consistent with it being an athletic trainer who would implement such a policy. It’s worth recognizing that only 7% of administrators contacted completed the survey. Therefore, these results may not accurately reflect what is happening in high schools across the country. One possibility is that people more interested in policy or heat illness completed the survey. So these results may show us the best-case scenario for written policies (78%) that include all components (6%) – which is a worrying sign.

    Clinical implications

    Encouraging state mandates and schools to hire athletic trainers can ensure that there are written policies to address heat illness. Clinicians may also want to consider strategies to educate coaches and parents/guardians about the reasons for this policy, such as rectal thermometers and cold water plunge pools.

    Questions for discussion

    Are you having trouble adding rectal temperature to your exercise heat illness protocol? Do you communicate with your athletics administrator regarding the approval, implementation and annual review/practice of your emergency policy?

    related posts

    1. Management of exertional heat stroke still leaves something to be desired
    2. A little more education about heat stroke due to exertion could go a long way
    3. Clinical Pearl: prevention and treatment of exertional heat stroke
    4. Tag us! What do coaches know about heat stroke during exertion and the role of the athletic trainer?
    5. Follow guidelines to prevent exertional heat illness? Let’s reconsider these guidelines

    Written by Jane McDevitt
    Reviewed by Jeffrey Driban

    9 EBP CEU courses

    Source link

  • You Don’t Look Sick – Living with Rheumatoid Arthritis: HAWAII DAY 1

    Well, my start to my trip to Hawaii definitely started with a bang. First I got up early and got to the airport well in time. I had a wonderful taxi driver who was very sweet and he took me and my luggage to the airport lobby and arranged a wheelchair for me. I was so early that I was ahead of the people pushing the wheelchairs to your gate. So I had to sit and wait for about half an hour for someone to push me to my gate.

    Getting through TSA was a lesson in patience. Since I was in a wheelchair, I was wheeled to the front of the line, but then had to wait for a female TSA agent to check my trunk. My boot had to be taken off and put through the X-ray machine and then my sock had to be inspected. I offered to take off my sock and they can take it to the x-ray machine, but they refused and instead felt all over my foot. It seemed kind of stupid. That whole process took about another 45 minutes.

    My flight was very nice. I sat next to two very nice women who both wore masks the entire time and we were super helpful when we landed. In Hawaii the plane lands right on the tarmac and you have to walk down a flight of stairs. The two women carried my backpack and medicine bag so I could hold on to the railing.

    Once I had my luggage, I waited in a long line to get the shuttle to the rental car. When I got to the rental car, I went to the Fast Track thinking I would get my rental car, but unfortunately they claimed I didn’t have my fast track for this reservation. So I had to wait in a long line for him to pick up my rental car. Luckily there were some very nice people in line who held my seat while I sat down for a while. It was very hot and I stood for a long time.

    Finally I get to the front of the line and pick up my rental car. I drove away happily and went to the supermarket to get food. I drove just 20 miles further and it was clear something was wrong with the car. Every time I drove over 60 miles per hour there was a chattering sound like someone was banging in the trunk. After stopping a few times to see if I could see what the problem was, I called roadside assistance. That was an incredibly useless call because the guy kept asking me where I was, but I just knew I was on a highway in the middle of nowhere in Hawaii. So I finally turned around and went back to the airport.

    AVvXsEgRy9qBgcR6vJg4f6G3U3pVjAhTWaud7nZq mFSPBLXKiJlAPBJUS E

    Once back at the car rental company at the airport, I saw the same service representative I had spoken to twice. I called him and told him what happened and he quickly brought my new car over.

    When the car came by, I had some really nice people helping me with my bags and groceries. This time the car was great. I arrived at the hotel and the nice lady at the reception helped me with my bags and groceries.

    To give you an idea, I landed at 11:30 AM and arrived at the hotel at 6:00 PM. It took 6.5 hours to get off the plane, pick up my luggage, go to the rental location, get car #1, then a grocery store and drive 20 miles and then drive back and get car #2 and then drive 2 hours to the hotel. It was a lot of standing. Let’s see how my feet feel tomorrow. Oh yeah, I was late for dinner, so I ate snacks.

    See you tomorrow…

    Source link

  • New research further confirms the benefits of exercise for bone health

    New research further confirms the benefits of exercise for bone health

    A new study has linked physical activity levels to several key health indicators, including bone mineral density and body fat percentage.

    In this article we delve into the details of this research. You’ll learn what these results mean for savers and how you can use them to build stronger bones and a longer, more independent life.

    About the study

    A study published in June in the journal Scientific Reports analyzed the impact of sedentary activity and physical activity on bone mineral density (BMD) and body fat percentage.

    Researchers used data from the National Health and Nutrition Examination Survey of 9,787 participants in America between the ages of 20 and 59 between 2011 and 2018.

    Participants’ activity levels were evaluated using questionnaires that asked about the number of hours per day they spent engaging in vigorous or moderate physical activity and being sedentary. Dual-energy X-ray absorptiometry (DXA) scans were used to measure bone mineral density and total body fat percentage.

    The researchers then analyzed the relationships between different data points, taking into account factors known to influence BMD and body fat, such as age, smoking, alcohol intake, protein levels, vitamin D and serum uric acid levels.1

    Short content

    A study of 9,787 Americans assessed the impact of sedentary activity and physical activity on bone mineral density and body fat percentage using questionnaires and DEXA scans. Scientists analyzed the data and took into account confounding factors that could also have affected the outcomes.

    Sedentary time decreases bone density and increases fat levels

    The researchers discovered a negative correlation between time spent sedentary and bone mineral density of the lumbar spine. Less active participants had lower bone mineral density.1

    The time the participants spent sedentary correlated positively with total body fat percentage. The less active the participants were, the higher their total fat content.

    The opposite relationships were observed for physical activity levels.

    Participants who spent more time moving their bodies had higher bone mineral density and lower total body fat percentage.

    Short content

    The researchers found that sedentary participants had lower bone mineral density and higher body fat percentage. More physically active participants had higher bone mineral density and lower body fat percentage.

    How a sedentary lifestyle breaks down your bones

    Wolff’s law describes the positive relationship between using your muscles and building your bones. It notes that bot adapts to use. The more you use a part of your body, the more bone mass your body builds to enable that use. Considering Wolff’s law, it makes sense that a sedentary lifestyle would result in less dense and less healthy bone.

    The authors of this study further explained why sedentary activity leads to bone loss. They noted that previous studies linked sedentary behavior to the production of parathyroid hormones, which negatively impacts calcium metabolism.

    They also noted that a sedentary lifestyle typically involves more indoor activities, resulting in reduced exposure to sunlight. This limits the body’s ability to produce vitamin D and disrupts skeletal homeostasis.

    Additionally, the study linked reduced physical activity to a higher percentage of body fat. The researchers noted that reducing body fat percentage reduces the risks associated with obesity, including cardiovascular disease, diabetes and cancer.

    Short content

    The negative influence of sedentary behavior on bone mass can be explained by Wolff’s law, which states that bone adapts to use. The study authors also suggested that causes of bone loss and increased fat may include higher production of parathyroid hormones and a lack of vitamin D production due to sedentary behavior and indoor activities. Lowering body fat percentage reduces the risks associated with obesity, including cardiovascular disease, diabetes and cancer.

    The relative importance of bone mineral density

    Bone mineral density is not the only measure of bone health. It might not even be the most useful. In part, this is because there are healthy and unhealthy forms of increased BMD.

    Bone density does not equal health or strength. The extra density caused by osteoporosis drugs such as bisphosphonates occurs by distorting the bone remodeling process. This pharmaceutical intervention prevents the removal of old and damaged bone mass, making it denser but less healthy. This causes the negative consequences associated with the use of these medications, such as an atypical femur fracture.

    However, the bone mineral density added by the body’s response to healthy behaviors such as exercise is natural and ensures lasting strength and quality. This study examined the impact of physical activity on bone mineral density, so that increase in BMD was natural and would likely help these participants maintain an active life while avoiding fractures.

    Short content

    Bone mineral density (BMD) is not necessarily a good indicator of bone health and strength. BMD added through the use of osteoporosis medications prevents the removal of old and damaged bone cells. That pharmaceutically modified bone becomes brittle, leading to side effects such as an atypical femur fracture. BMD added through physical activity utilizes the complete, natural bone remodeling cycle, creating strong and healthy bones.

    What this means for you

    Consider how much time you spend doing physical activities versus how much time you spend being sedentary. Today’s research clearly shows the value of trading sedentary time for more physical activity.

    Take a walk, go for a swim, go to the gym, do some yard work, play with your grandkids – there are lots of ways to get up and get moving.

    Exercise is a necessity for building healthy and strong bones. That’s why we created SaveTrainer. SaveTrainer is an online training platform that gives you exactly what you need to build an enjoyable, sustainable practice of regular exercise.

    Our professional trainers create expertly guided video sessions at every level, so you can start where you are and grow at your own pace. Best of all, this resource is available anytime, anywhere.

    The results are clear: get moving so you can keep moving. Stronger bones and a healthier life await you.

    References

    1 https://www.nature.com/articles/s41598-023-35742-z



    Source link

  • Orthofix announces the full commercial launch of the WaveForm L Interbody System for lateral lumbar fusion procedures

    Orthofix announces the full commercial launch of the WaveForm L Interbody System for lateral lumbar fusion procedures

    LEWISVILLE, Texas, November 6, 2023–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch in the U.S. of the WaveForm® L Lateral lumbar interbody system. Designed for lateral lumbar interbody fusion (LLIF) procedures, the 3D printed WaveForm L features a porous structure that prioritizes strength and stability to provide a robust fusion environment.

    “Designed to safely and reproducibly treat the spine via indirect decompression and sagittal alignment restoration, the WaveForm L features a large core opening for the placement of bone graft material to optimize bone fusion throughout the body,” said Dr. Donald Blaskiewicz, director of Spinal Malformation at St. Luke’s Boise Medical Center in Boise, Idaho, and faculty at UCSD in San Diego, CA. “The WaveForm L also has enhanced imaging properties to assist with radiographic visualization during intra- and postoperative imaging. These combined features make it one of the best 3D printed interbodies available.”

    WaveForm interbodies are uniquely created with a primary focus on structure, surface and stability. Constructed from a repeating wave-like structure, WaveForm L is designed to efficiently distribute compressive loads and provide high porosity for optimized stiffness without compromising strength.1,2 With an 80 percent body porosity, WaveForm L provides improved imaging properties and greater graft packability, while the optimized 65 percent endplate porosity of the wave-like structure provides bone ingrowth and early mechanical stability.3,4,5

    “We are committed to delivering a comprehensive portfolio of innovative, procedurally focused products that are strategically designed to work together to drive fusion,” said Kevin Kenny, president of Orthofix Global Spine. “WaveForm L represents the latest developments in patented spinal implant technology, which is designed to address the many nuances of spinal pathology to meet the individual needs of patients, providing both clinical and economic value to patients, surgeons and hospital systems.”

    Lateral lumbar interbody fusion (LLIF) procedures represent approximately 20 percent of the interbody device market. The number of these procedures is expected to continue to increase based on the rapid growth of titanium-coated PEEK devices and 3D printed metal devices. According to 2022 data, the LLIF market in the US is estimated at over $350 million.6

    1. Data available, TM-0043-22
    2. Kelly, Cambre N., et al. “Design and structure-function characterization of 3D printed synthetic porous biomaterials for tissue engineering.” Advanced Healthcare Materials 7.7 (2018): 1701095.
    3. Data available, TM-0071-23
    4. Data available, D0006845
    5. Kelly, C.N., Wang, T., Crowley, J., Wills, D., Pelletier, M.H., Westrick, E.R., Adams, S.B., Gall, K., & Walsh, W.R. (2021). High-strength, porous, additively manufactured implants with optimized mechanical osseointegration. Biomaterials, 279, 121206. https://doi.org/10.1016/j.biomaterials.2021.121206
    6. Data on file. Market estimates based on iData 2022 US Market Report Suite for Spinal Impants and MIS.

    About Orthofix

    Orthofix and SeaSpine merged in January 2023 to form a leading global spine and orthopedics company with an extensive portfolio of biologics, innovative spine hardware, bone growth therapies, specialty orthopedic solutions and a leading surgical navigation system. The products are distributed in approximately 68 countries around the world.

    The company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and corporate offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy. with an emphasis on product innovation, production and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil. For more information, visit Orthofix.com.

    Forward-Looking Statements

    This press release may contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects” , ‘intends’, ‘predicts’, ‘potential’, ‘continue’ or other similar terminology. Orthofix cautions you that statements in this press release that are not descriptions of historical facts are forward-looking statements based on the company’s current expectations and assumptions. Any forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, but are not limited to: the ability of newly launched products to perform as designed and intended and to meet the needs of surgeons and patients, including due to the lack of robust clinical validation; and the risks identified under the heading “Risk Factors” in Orthofix Medical Inc.’s annual report. on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the Securities and Exchange Commission (SEC) on March 6. , 2023. The Company’s public filings with the Securities and Exchange Commission are available at www.sec.gov. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made. Orthofix does not intend to revise or update any forward-looking statement contained in this press release to reflect events or circumstances occurring after the date of this press release, except as may be required by law.

    Contacts

    Media relations
    Denise Landry
    DeniseLandry@orthofix.com
    214.937.2529

    Investor Relations
    Louisa Smith, Gilmartin Group
    IR@orthofix.com

    Source link

  • Easy Fried Colossal Shrimp |  GF |  BoneCoach™ Recipes – BoneCoach™

    Easy Fried Colossal Shrimp | GF | BoneCoach™ Recipes – BoneCoach™

    Looking for a flawless fish dish that anyone can make?

    This is it!

    Our Easy Baked Colossal Shrimp delivers effortless taste with just a short list of simple, everyday ingredients.

    Plus, it’s ready in just 10 minutes, making it perfect for a weeknight dinner or to impress party guests at a special occasion.

    Plus, this simple recipe is a nutritional powerhousewith protein, omega-3 fatty acids, selenium, phosphorus, vitamin B12 and vitamin C in every serving.

    We’re sure you’ll love our Easy Baked Colossal Shrimp!

    SERVES: 2

    TOTAL TIME: 10 minutes

    Ingredients

    227 g raw colossal shrimp

    1 tablespoon (15 ml) butter (or ghee or freshly pressed extra virgin olive oil)

    1 clove garlic, minced

    1 teaspoon (5 ml) lemon zest

    1/4 teaspoon (1 ml) sea salt

    Directions

    1) Preheat oven to 350F. Mix the butter and garlic in an ovenproof baking dish. Place in the oven for 30 seconds, just enough time for the butter to melt. Remove the dish from the oven.

    2) Add the shrimp, lemon zest and salt. Toss the shrimp so that they are completely covered and arrange them in a single layer. Cook for 10 minutes until the shrimp are fully cooked. Serve immediately and garnish with fresh herbs as desired.

    Recipe created by BoneCoach™ Team Dietitian Amanda Natividad-Li, RD & Chef.

    Medical disclaimer

    The information shared above is for informational purposes only and is not intended as medical or nutritional therapy advice; it does not diagnose, treat or cure any disease or condition; it should not be used as a substitute or substitute for medical advice from physicians and trained medical professionals. If you are under the care of a healthcare professional or are currently taking prescription medications, you should discuss any changes in your diet and lifestyle or possible use of nutritional supplements with your doctor. You should not stop prescribed medications without first consulting your doctor.

    Source link